PARK INNOVAARE

Blog

The ace up the sleeve of PARK INNOVAARE

As part of the Swiss innovation park with its international operations, PARK INNOVAARE is contributing to the sustainability of the Swiss federal economy....

More details

Structure-based drug discovery drives the development of novel treatment options

Drug development is a long and unpredictable process that requires high levels of investment, endurance and state-of-the-art technology. Basic research...

More details

PARK INNOVAARE paves the way for jobs of tomorrow

Today’s innovations will be tomorrow’s products and jobs. Even now, Switzerland has one of the most innovative economies in the world. It will take...

More details More details

New opportunities for innovative SMEs

The European Union (EU) has realized that too few newly developed products are making it onto the market in Europe. For this reason, it is utilizing the...

More details

Energy is in the air

It is hard to imagine today’s world without energy: our everyday life, our economies and our future depend on it. That is why it is crucial to find sustainable...

More details More details

Shaping the future of modern drug discovery

Video interview with Professor Dr. Gebhard Schertler Pharmaceutical and biotechnological industries often depend on the information acquired through...

More details

Women’s passion – the new frontier of innovation

Based on the “Appassionate” project – a book about women who transform their own passion into enterprises My work has always been to find stories...

More details

Emerging applications of modular nanomaterials

When, back in 1999, the journal Nature published a letter about a material with a surface area of 2900 square meters in a single gram, many people believed...

More details

Life Science basic research on the top level

The Paul Scherrer Institute (PSI) is Switzerland’s biggest research institute for natural and engineering sciences. It hosts most of the country’s...

More details More details

A perfect site for biotech and pharma companies!

Drug discovery has come a long way from crude extracts to pure chemicals, from guess work to a structural and targeted approach to finding new and better...

More details

Infrastructure and R&D solutions for biotech and pharmaceutical industries

The Swiss Light Source (SLS) at the Paul Scherrer Institute (PSI) and the free-electron laser (SwissFEL) provide beams of exceptional brightness and stability...

More details

Biotech and pharma at PARK INNOVAARE

PARK INNOVAARE provides the best possible operating conditions for biotech and pharmaceutical companies. This includes the availability of modern laboratories...

More details